封面
市场调查报告书
商品编码
1974952

全球血栓除去装置市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Thrombectomy Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计血栓切除器材市场将从 2025 年的 24.8 亿美元成长到 2034 年的 48.7 亿美元,2026 年至 2034 年的复合年增长率为 7.79%。

血栓除去装置。血栓除去装置用于清除动脉中的血栓,恢復正常血流,因此在中风急救中至关重要。人们对早期中风介入的认识不断提高,以及医疗基础设施的改善,都促进了市场成长。

关键驱动因素包括微创手术技术的进步和多个地区有利的健保报销政策。医疗机构正在扩大机械取栓术的使用,因为与传统治疗方法相比,它更有效且能带来更快的復健。人口老化和文明病的增加进一步推高了对先进取栓设备的需求。

未来,技术创新可望提升设备的精准性和安全性。开发中国家医疗保健服务的普及将创造新的成长机会。持续进行的临床研究和专家培训计画将进一步促进设备的普及。随着卒中管理通讯协定的不断完善,血栓切除设备市场预计将在全球范围内实现永续成长。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球血栓除去装置市场:依技术划分

  • 市场分析、洞察与预测
  • 机械血栓切除术
  • 抽吸血栓切除手术
  • 再血管血栓切除术

第五章 全球血栓除去装置市场:按类型划分

  • 市场分析、洞察与预测
  • 自动化设备
  • 手动装置

第六章 全球血栓除去装置市场:依应用领域划分

  • 市场分析、洞察与预测
  • 可重复使用设备
  • 免洗设备

第七章 全球血栓除去装置市场:依应用领域划分

  • 市场分析、洞察与预测
  • 週边疾病
  • 冠状动脉疾病
  • 神经系统疾病

第八章 全球血栓除去装置市场:按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第九章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第十章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Johnson And Johnson
    • Koninklijke Philips NV
    • Boston Scientific Group
    • Medtronic Plc
    • Terumo Corporation
    • Abbott Laboratories
    • AngioDynamics Inc
    • Penumbra Inc
    • Teleflex Incorporated
    • Stryker Corporation
简介目录
Product Code: VMR112110828

The Thrombectomy Devices Market size is expected to reach USD 4.87 Billion in 2034 from USD 2.48 Billion (2025) growing at a CAGR of 7.79% during 2026-2034.

The Global Thrombectomy Devices Market is growing rapidly due to the increasing incidence of stroke and cardiovascular diseases worldwide. Thrombectomy devices are used to remove blood clots from arteries and restore normal blood flow, which is critical in emergency stroke treatment. Rising awareness about early stroke intervention and improved healthcare infrastructure are contributing to market growth.

Major drivers include advancements in minimally invasive surgical technologies and favorable reimbursement policies in several regions. Healthcare providers are increasingly adopting mechanical thrombectomy procedures due to their effectiveness and faster recovery times compared to traditional treatments. The aging population and lifestyle-related health conditions are further increasing the demand for advanced clot removal devices.

In the future, technological innovation is expected to enhance device precision and safety. Expanding healthcare access in developing countries will create new growth opportunities. Ongoing clinical research and training programs for specialists will further support adoption. With continued improvements in stroke management protocols, the thrombectomy devices market is set for sustained expansion globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Mechanical Thrombectomy
  • Aspiration Thrombectomy
  • Rheolytic Thrombectomy

By Type

  • Automated Devices
  • Manual Devices

By Utility

  • Reusable Devices
  • Disposable Devices

By Application

  • Peripheral Diseases
  • Coronary Disease
  • Neural Diseases

COMPANIES PROFILED

  • Johnson and Johnson, Koninklijke Philips NV, Boston Scientific Group, Medtronic plc, Terumo Corporation, Abbott Laboratories, AngioDynamics Inc, Penumbra Inc, Teleflex Incorporated, Stryker Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL THROMBECTOMY DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Mechanical Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Aspiration Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Rheolytic Thrombectomy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THROMBECTOMY DEVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Automated Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Manual Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THROMBECTOMY DEVICES MARKET: BY UTILITY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Utility
  • 6.2. Reusable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Disposable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL THROMBECTOMY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Peripheral Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Coronary Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Neural Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL THROMBECTOMY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Technology
    • 8.2.2 By Type
    • 8.2.3 By Utility
    • 8.2.4 By Application
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Technology
    • 8.3.2 By Type
    • 8.3.3 By Utility
    • 8.3.4 By Application
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Technology
    • 8.4.2 By Type
    • 8.4.3 By Utility
    • 8.4.4 By Application
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Technology
    • 8.5.2 By Type
    • 8.5.3 By Utility
    • 8.5.4 By Application
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Technology
    • 8.6.2 By Type
    • 8.6.3 By Utility
    • 8.6.4 By Application
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL THROMBECTOMY DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Johnson And Johnson
    • 10.2.2 Koninklijke Philips N.V
    • 10.2.3 Boston Scientific Group
    • 10.2.4 Medtronic Plc
    • 10.2.5 Terumo Corporation
    • 10.2.6 Abbott Laboratories
    • 10.2.7 AngioDynamics Inc
    • 10.2.8 Penumbra Inc
    • 10.2.9 Teleflex Incorporated
    • 10.2.10 Stryker Corporation